| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/21/2011 | CA2777226A1 Cancer treatment |
| 04/21/2011 | CA2776712A1 Use of il-17 receptor a antigen binding proteins |
| 04/21/2011 | CA2775959A1 Dual variable domain immunoglobulins and uses thereof |
| 04/21/2011 | CA2775402A1 Il-1 binding proteins |
| 04/21/2011 | CA2775277A1 Infectious clones of torque teno virus |
| 04/20/2011 | EP2312318A1 Prion protein ligands and methods of use |
| 04/20/2011 | EP2312316A1 Anti-EPHA2 antibodies as a cancer diagnostic |
| 04/20/2011 | EP2311980A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/20/2011 | EP2311979A1 Compositions, kits and methods for identification, assessment, prevention and therapy of cervical cancer |
| 04/20/2011 | EP2311978A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/20/2011 | EP2311973A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/20/2011 | EP2311957A1 Antigens from granulocytic Ehrlichia |
| 04/20/2011 | EP2311955A2 Osteoprotegerin binding proteins and their receptors |
| 04/20/2011 | EP2311954A1 Mutations in the Parkin gene, compositions, methods and uses |
| 04/20/2011 | EP2311952A2 Antibodies to MRT-1 protein or fragments thereof |
| 04/20/2011 | EP2311951A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 04/20/2011 | EP2311950A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 04/20/2011 | EP2311946A1 Anti-system asc amino acid transporter 2 (asct2) antibody |
| 04/20/2011 | EP2311945A1 Bispecific antibodies substituting for functional proteins |
| 04/20/2011 | EP2311944A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 04/20/2011 | EP2311882A1 Reducing the immunogenicity of fusion proteins |
| 04/20/2011 | EP2311881A2 Cripto binding molecules |
| 04/20/2011 | EP2311880A2 Cripto binding molecules |
| 04/20/2011 | EP2311879A2 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 04/20/2011 | EP2311878A2 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 04/20/2011 | EP2311877A2 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 04/20/2011 | EP2311876A2 M-CSF-specific monoclonal antibody and uses thereof |
| 04/20/2011 | EP2311875A1 Treatment with anti-VEGF antibodies |
| 04/20/2011 | EP2311874A2 Binding molecules |
| 04/20/2011 | EP2311873A1 M-CSF-specific monoclonal antibody and uses thereof |
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311870A1 Compositions and methods for the treatment of immune related diseases |
| 04/20/2011 | EP2311869A1 Use of mammalian cytokine; related reagents |
| 04/20/2011 | EP2311868A1 Compositions and methods for the treatment of immune related diseases |
| 04/20/2011 | EP2311867A1 Trimeric binding proteins for trimeric cytokines |
| 04/20/2011 | EP2311862A2 Differential in tumour gene products and use of same |
| 04/20/2011 | EP2311861A2 Differential in tumour gene products and use of same |
| 04/20/2011 | EP2311860A2 Differential in tumour gene products and use of same |
| 04/20/2011 | EP2311859A1 Uses of a novel Eimeria gene and corresponding protein |
| 04/20/2011 | EP2311849A1 Specific binding agents of human angiopoietin-2 |
| 04/20/2011 | EP2311493A1 Cytotoxic composition |
| 04/20/2011 | EP2311492A1 Antibody-containing stabilized preparations |
| 04/20/2011 | EP2311491A1 Composition comprising an antibody against macrophage colony-stimulating factor (M-CSF) and a chelating agent |
| 04/20/2011 | EP2311490A2 Uses of antibodies to aminophospholipids for cancer treatment |
| 04/20/2011 | EP2311489A2 Formulation of antibody-containing solutions comprising a sugar as a stabilizer |
| 04/20/2011 | EP2311485A1 Thymosin beta 4 promotes wound repair |
| 04/20/2011 | EP2311484A1 Use of IL-12 and IL-12 antagonists for the manufacture of a pharmaceutical composition for the treatment of autoimmune diseases |
| 04/20/2011 | EP2311468A1 Gene overexpressed in cancer |
| 04/20/2011 | EP2310850A1 A diagnostic method |
| 04/20/2011 | EP2310508A1 Tgf-b antagonist multi-target binding proteins |
| 04/20/2011 | EP2310417A1 Oxidized ldl specific antibody-fusion and conjugated proteins |
| 04/20/2011 | EP2310416A1 Anti-gd2 antibodies and methods and uses related thereto |
| 04/20/2011 | EP2310415A2 Antibodies against fcrn and use thereof |
| 04/20/2011 | EP2310414A1 Pax 5 monoclonal antibody |
| 04/20/2011 | EP2310413A2 Camelid derived antigen binding polypeptides |
| 04/20/2011 | EP2310412A2 Immunoglobulins with reduced aggregation |
| 04/20/2011 | EP2310410A2 Tnf- antagonist multi-target binding proteins |
| 04/20/2011 | EP2310034A2 Compounds for treating beta-amyloidoses |
| 04/20/2011 | EP2310033A2 Compounds for treating amyloidoses |
| 04/20/2011 | EP2310032A2 Compounds for treating symptoms associated with parkinson's disease |
| 04/20/2011 | EP1966375B1 Vector for efficient selection and/or maturation of an antibody and uses thereof |
| 04/20/2011 | EP1680140B1 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 04/20/2011 | EP1624892B1 Therapeutic use of anti-cs1 antibodies |
| 04/20/2011 | EP1578361B1 Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
| 04/20/2011 | EP1529063B1 Antibodies anti-c5 component of the complement system and their use |
| 04/20/2011 | EP1451223B1 Expression control using variable intergenic sequences |
| 04/20/2011 | EP1385993B1 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 04/20/2011 | EP1227159B1 Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit |
| 04/20/2011 | EP1224461B1 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 04/20/2011 | CN1993468B Polypeptides having DNA polymerase activity |
| 04/20/2011 | CN1849395B HLA-a24 binding cancer antigen peptide derived from ribin |
| 04/20/2011 | CN1701117B Antibody against enzyme specifically cleaving VON WILLEBRAND factor and assay system using the same |
| 04/20/2011 | CN1643148B Mouse spermatogenesis genes, human male sterility-associated genes and diagnostic system using the same |
| 04/20/2011 | CN1628179B Detection of hepatocellular carcinoma |
| 04/20/2011 | CN102027372A Method for detection of liver cancer cell using anti-glypican-3 antibody |
| 04/20/2011 | CN102027018A Agent for treating disease |
| 04/20/2011 | CN102027017A Agent for treating disease |
| 04/20/2011 | CN102027016A Agent for treating disease |
| 04/20/2011 | CN102027015A Anti-CXCR4 antibodies |
| 04/20/2011 | CN102027014A Novel antibodies used to treat cancer |
| 04/20/2011 | CN102027013A Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof |
| 04/20/2011 | CN102027012A Methods and compositions for treating allergic diseases |
| 04/20/2011 | CN102027011A Anti-human IL-21 monoclonal antibodies |
| 04/20/2011 | CN102027010A Antibody purification process |
| 04/20/2011 | CN102027009A Antibodies with enhanced ADCC function |
| 04/20/2011 | CN102027006A Novel and powerful MHC-class II petptides derived from survivin |
| 04/20/2011 | CN102026672A C2ORF18 as target gene for cancer therapy and diagnosis |
| 04/20/2011 | CN102026659A Method for the prevention and treatment of cancer by inhibition of GPVI |
| 04/20/2011 | CN102026658A Improved immunizing composition |
| 04/20/2011 | CN102021184A Antigenic polypeptides |
| 04/20/2011 | CN102021153A Human telomerase catalytic subunit |
| 04/20/2011 | CN102021146A West nile virus NS1 protein monoclonal antibody, identified B cell epitope thereof and application |
| 04/20/2011 | CN102020715A Anti-procollagen III N-terminal peptide monoclonal antibody and application thereof |
| 04/20/2011 | CN102020714A Colloidal gold test paper for jointly detecting abrin and ricin and special monoclonal antibody |
| 04/20/2011 | CN102020713A Immune colloidal gold test strip used for detecting aureomycin residue and preparation method thereof |
| 04/20/2011 | CN101555477B Heavy and light chain variable region gene of monoclonal antibody resisting human amyloid protein, and its uses |
| 04/20/2011 | CN101362798B Candida albicans hyphal development inhibitor and application thereof |
| 04/20/2011 | CN101307104B Recombination escherichia coli with Z9CCK protein, yolk antibody and applications |
| 04/19/2011 | US7930107 Methods of generating variant proteins with increased host string content |
| 04/19/2011 | US7928205 Methods for refolding of recombinant antibodies |